Tue. Aug 16th, 2022
Acute Respiratory Distress Syndrome Market

Acute Respiratory Distress Syndrome Market Report gives readers a thorough assessment of key market drivers, restraints, prospects, opportunities, restraints, current trends, and technological and industrial breakthroughs that will influence market growth. The detailed market research, industry sector growth and development, and new product introductions covered in this report on the Acute Respiratory Distress Syndrome Market are of great assistance to the important new commercial players joining the market.

This Acute Respiratory Distress Syndrome Market report research conducts a careful market evaluation and provides a professional analysis of the industry taking into account market development, present market circumstances, and forecasts for the future. The market driving factors, market overview, industry volume, and market share are also highlighted in this Acute Respiratory Distress Syndrome Market report analysis.

Regions Covered in the Report-

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Click the link to get a Sample Copy of the Report before purchase: https://www.delveinsight.com/sample-request/acute-respiratory-distress-syndrome-ards-market

Acute Respiratory Distress Syndrome: An Overview

Acute respiratory distress syndrome (ARDS) is a severe lung condition that causes low blood oxygen. People who develop ARDS are usually ill due to another disease or a major injury. In ARDS, fluid builds up inside the tiny air sacs of the lungs, and surfactant breaks down. ARDS may develop over a few days, or it can get worse very quickly. Usually, the first symptom of ARDS is shortness of breath. Besides, other signs and symptoms of ARDS are low blood oxygen, rapid breathing, and clicking, bubbling, or rattling sounds in the lungs when breathing.

Key highlights of the Acute Respiratory Distress Syndrome Market Report

  • Total incident cases of Acute Respiratory Distress Syndrome in the 7MM were found to be 1,187,682 cases in 2021. These cases are expected to change by 2032 at a CAGR of 1.5%during the study period (2019–2032).
  • Among 7MM, the United States has the highest number of incident cases of Acute Respiratory Distress Syndrome with 634,515 cases in 2021.
  • Assessments as per DelveInsight’s analysts show that in terms of severity-specific incidence, a similar trend is observed in all countries, with a majority of the cases pointing to moderate ARDS, except France, where severe cases of ARDS accounted for a maximum patient population.
  • In the United States, there were a total of 190,355, 295,684, and 148,477 severity-specific cases of mild, moderate, and severe Acute Respiratory Distress Syndrome respectively, in 2021. As per DelveInsight’s analysts, the severity-specific cases of Acute Respiratory Distress Syndrome will increase by 2032.
  • In EU-5, Germany has the highest number of incident cases of Acute Respiratory Distress Syndrome with 216,462 cases in 2021, followed by France with 115,168 cases and Italy with 72,878  While the United Kingdom has the least number of cases with 36,976 in 2021.
  • In 2021, Japan had 73,039 incident cases of Acute Respiratory Distress Syndrome.

Acute Respiratory Distress Syndrome Epidemiology Insights

Acute Respiratory Distress Syndrome (ARDS), a life-threatening condition, was described as a form of respiratory failure that closely resembled respiratory distress syndrome in infants. It can be caused by a variety of pulmonary (such as pneumonia, aspiration) or non-pulmonary (like sepsis, pancreatitis, and trauma) abuses, leading to the development of non-hydrostatic pulmonary edema.

Acute Respiratory Distress Syndrome Epidemiology Segmentation in the 7MM

  • Total Incident Population
  • Incident Population by Risk Factors
  • Severity-Specific Incident Population

Acute Respiratory Distress Syndrome Treatment Market

Acute Respiratory Distress Syndrome treatment options, which the patients with ARDS are generally subjected include supplemental oxygen, prone positioning, use of paralytics, fluid management, and a technique called positive end-expiratory pressure (PEEP) to help push the fluid out of air sacs. These are combined with continuing treatment of the original illness or injury. Because people with ARDS are less able to fight lung infections, they may develop bacterial pneumonia during the illness. Antibiotics are given to fight infection. Also, supportive treatment, such as intravenous fluid or food, may be needed.

Acute Respiratory Distress Syndrome Market Insights

In ARDS, the evolution of systemic and pulmonary inflammation in the 1st week of mechanical ventilation determines the physiologic progression (resolving vs unresolving) and the outcome of the disease. Glucocorticoids as end-effectors of the hypothalamic-pituitary-adrenal axis are the most important physiologic inhibitors of inflammation, affecting hundreds of genes involved in stress-related homeostasis. At the cellular level, glucocorticoids exert their effects by activating cytoplasmic heat shock protein-complexed glucocorticoid receptors, which in turn, interact with activated nuclear factor-κB to prevent DNA binding and subsequent transcriptional activity.

Acute Respiratory Distress Syndrome Market Forecast

Despite decades of research, treatment options for ARDS are restricted. Supportive care with mechanical ventilation remains the mainstay of management. There are relatively few treatments available for ARDS. Other treatment options, which the patients with ARDS are subjected to generally include supplemental oxygen, prone positioning, use of paralytics, fluid management, and a technique called positive end-expiratory pressure (PEEP) to help push the fluid out of air sacs. These are combined with continuing treatment of the original illness or injury. Because people with ARDS are less-abled to fight lung infections, they may develop bacterial pneumonia during the illness. Antibiotics are given to fight infection. Also, supportive treatment, such as intravenous fluid or food, may be needed.

Acute Respiratory Distress Syndrome Market Size

The market size shall grow during the forecast period owing to the launch of upcoming therapies and is expected to increase at a significant rate during the study period. The United States contributed USD 709.61 Million to the 7MM ARDS market in 2020.

Make an Enquiry Before Buying- https://www.delveinsight.com/sample-request/acute-respiratory-distress-syndrome-ards-market

Table of Content

  1. Key Insights
  2. Executive Summary
  3. Competitive Intelligence Analysis for Acute Respiratory Distress Syndrome
  4. Acute Respiratory Distress Syndrome Market Overview at a Glance
  5. Acute Respiratory Distress Syndrome Disease Background and Overview
  6. Patient Journey
  7. Acute Respiratory Distress Syndrome Epidemiology and Patient Population
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Acute Respiratory Distress Syndrome Unmet Needs
  10. Key Endpoints of Acute Respiratory Distress Syndrome Treatment
  11. Acute Respiratory Distress Syndrome Marketed Products
  12. Acute Respiratory Distress Syndrome Emerging Therapies
  13. Acute Respiratory Distress Syndrome Seven Major Market Analysis
  14. Attribute analysis
  15. 7MM: Acute Respiratory Distress Syndrome Market Outlook
  16. Access and Reimbursement Overview of Acute Respiratory Distress Syndrome
  17. KOL Views
  18. Acute Respiratory Distress Syndrome Market Drivers
  19. Acute Respiratory Distress Syndrome Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer
  23. About DelveInsight

Acute Respiratory Distress Syndrome Market Report Highlights

  • In the coming years, the Acute Respiratory Distress Syndrome market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Acute Respiratory Distress Syndrome R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
  • Major players are involved in developing therapies for Acute Respiratory Distress Syndrome. The launch of emerging therapies will significantly impact the Acute Respiratory Distress Syndrome market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Acute Respiratory Distress Syndrome
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Why should you buy this report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Acute Respiratory Distress Syndrome market
  • To understand the future market competition in the Acute Respiratory Distress Syndrome market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Acute Respiratory Distress Syndrome in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Acute Respiratory Distress Syndrome market
  • To understand the future market competition in the Acute Respiratory Distress Syndrome market

Get in touch with our Business Expert @ Business Consulting Services | Biotech Consulting | Technical Due Diligence Firms

Trending & Popular Market Research Reports 2022 by Delveinsight

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Contact Us

Yash

[email protected]

 

By krehani

Leave a Reply

Your email address will not be published. Required fields are marked *